Skip to main content
Top

03-02-2025

Demographic Disparities and Factors Influencing Cancer Treatment Decision-Making

Authors: Safa Elkefi, Avishek Choudhury

Published in: Journal of Cancer Education

Login to get access

Abstract

This study aims to explore disparities in cancer treatment decision-making and the factors associated with the decision to pursue treatment. We used Behavioral Risk Factor Surveillance System (BRFSS) data collected between 2017 and 2022. We employed the PRECEDE-PROCEED model to guide our analysis of factors associated with treatment decisions. Descriptive statistics and multivariable logistic regression analysis were conducted to assess the association between treatment decision-making and the predisposing, enabling, and reinforcing factors (following the PRECEDE-PROCEED model). All analyses were weighted and adjusted for the demographic characteristics of the participants. Our sample included N = 19,388 cancer patients, 20.98% of whom refused treatment. American Indians, younger adults, and breast cancer patients were more likely to decide to go for treatment. Patients who had private insurance (OR = 1.25, P = .037) and those who did not have problems affording care (OR = 1.22, P = .02) were more likely to decide to get treatment. The more patients had regular doctors, the more they decided to continue to pursue treatment for cancer (Only one doctor: OR = 1.20, P = .042; More than one: OR = 1.28, P = .007). Finally, the more days patients experienced a bad health situation, the more they decided to have cancer treatment (for 14 + days with bad health: OR = 1.20, P < .001). The results suggest the need for enhanced patient education to improve cancer treatment adherence and informed decision-making. It highlights the importance of culturally tailored educational programs, age-related concerns, addressing financial barriers, and emphasizing the importance of regular healthcare visits for cancer patients.
Literature
1.
go back to reference Zugazagoitia J, Guedes C, Ponce S, Ferrer I, Molina-Pinelo S, Paz-Ares L (2016) Current challenges in cancer treatment. Clin Ther 38(7):1551–1566CrossRefPubMed Zugazagoitia J, Guedes C, Ponce S, Ferrer I, Molina-Pinelo S, Paz-Ares L (2016) Current challenges in cancer treatment. Clin Ther 38(7):1551–1566CrossRefPubMed
2.
go back to reference Miller KD et al (2022) Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin 72(5):409–436 Miller KD et al (2022) Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin 72(5):409–436
3.
go back to reference Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74(1):12–49 Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74(1):12–49
5.
go back to reference Huchcroft SA, Snodgrass T (1993) Cancer patients who refuse treatment. Cancer Causes Control 4:179–185CrossRefPubMed Huchcroft SA, Snodgrass T (1993) Cancer patients who refuse treatment. Cancer Causes Control 4:179–185CrossRefPubMed
6.
go back to reference Choi HG, Park B, Ahn S-H (2017) Untreated head and neck cancer in Korea: a national cohort study. Eur Arch Otorhinolaryngol 274:1643–1650CrossRefPubMed Choi HG, Park B, Ahn S-H (2017) Untreated head and neck cancer in Korea: a national cohort study. Eur Arch Otorhinolaryngol 274:1643–1650CrossRefPubMed
7.
go back to reference Chen SJ, Kung P-T, Huang KH, Wang Y-H, Tsai W-C (2015) Characteristics of the delayed or refusal therapy in breast cancer patients: a longitudinal population-based study in Taiwan. PLoS ONE 10(6):e0131305CrossRefPubMedPubMedCentral Chen SJ, Kung P-T, Huang KH, Wang Y-H, Tsai W-C (2015) Characteristics of the delayed or refusal therapy in breast cancer patients: a longitudinal population-based study in Taiwan. PLoS ONE 10(6):e0131305CrossRefPubMedPubMedCentral
8.
go back to reference Kaltenmeier C et al (2020) Refusal of cancer-directed treatment by colon cancer patients: Risk factors and survival outcomes. Am J Surg 220(6):1605–1612CrossRefPubMedPubMedCentral Kaltenmeier C et al (2020) Refusal of cancer-directed treatment by colon cancer patients: Risk factors and survival outcomes. Am J Surg 220(6):1605–1612CrossRefPubMedPubMedCentral
9.
go back to reference Dias LM, Bezerra MR, Barra WF, Rego F (2021) Refusal of medical treatment by older adults with cancer: a systematic review. Ann Palliat Med 10(4):4868877–4864877CrossRef Dias LM, Bezerra MR, Barra WF, Rego F (2021) Refusal of medical treatment by older adults with cancer: a systematic review. Ann Palliat Med 10(4):4868877–4864877CrossRef
10.
go back to reference Puts MT et al (2010) Characteristics of older newly diagnosed cancer patients refusing cancer treatments. Support Care Cancer 18:969–974CrossRefPubMed Puts MT et al (2010) Characteristics of older newly diagnosed cancer patients refusing cancer treatments. Support Care Cancer 18:969–974CrossRefPubMed
11.
go back to reference Elkefi S, Trapani D, Ryan S (2023) The role of digital health in supporting cancer patients' mental health and psychological well-being for a better quality of life: a systematic literature review. Int J Med Inform 105065 Elkefi S, Trapani D, Ryan S (2023) The role of digital health in supporting cancer patients' mental health and psychological well-being for a better quality of life: a systematic literature review. Int J Med Inform 105065
12.
go back to reference Hillen MA, De Haes HC, Smets EM (2011) Cancer patients’ trust in their physician—a review. Psychooncology 20(3):227–241CrossRefPubMed Hillen MA, De Haes HC, Smets EM (2011) Cancer patients’ trust in their physician—a review. Psychooncology 20(3):227–241CrossRefPubMed
13.
go back to reference Shepherd HL, Tattersall MH, Butow PN (2007) The context influences doctors’ support of shared decision-making in cancer care. Br J Cancer 97(1):6–13CrossRefPubMedPubMedCentral Shepherd HL, Tattersall MH, Butow PN (2007) The context influences doctors’ support of shared decision-making in cancer care. Br J Cancer 97(1):6–13CrossRefPubMedPubMedCentral
14.
go back to reference Hong Y-R, Salloum RG, Yadav S, Smith G, Mainous AG III (2020) Patient–provider discussion about cancer treatment costs and out-of-pocket spending: implications for shared decision making in cancer care. Value Health 23(12):1592–1598CrossRefPubMed Hong Y-R, Salloum RG, Yadav S, Smith G, Mainous AG III (2020) Patient–provider discussion about cancer treatment costs and out-of-pocket spending: implications for shared decision making in cancer care. Value Health 23(12):1592–1598CrossRefPubMed
15.
go back to reference Iachan R, Pierannunzi C, Healey K, Greenlund KJ, Town M (2016) National weighting of data from the behavioral risk factor surveillance system (BRFSS). BMC Med Res Methodol 16:1–12CrossRef Iachan R, Pierannunzi C, Healey K, Greenlund KJ, Town M (2016) National weighting of data from the behavioral risk factor surveillance system (BRFSS). BMC Med Res Methodol 16:1–12CrossRef
16.
go back to reference Guinn AS, Ports KA, Ford DC, Breiding M, Merrick MT (2019) Associations between adverse childhood experiences and acquired brain injury, including traumatic brain injuries, among adults: 2014 BRFSS North Carolina. Inj Prev 25(6):514–520CrossRefPubMed Guinn AS, Ports KA, Ford DC, Breiding M, Merrick MT (2019) Associations between adverse childhood experiences and acquired brain injury, including traumatic brain injuries, among adults: 2014 BRFSS North Carolina. Inj Prev 25(6):514–520CrossRefPubMed
17.
go back to reference Green LW, Kreuter M, Deeds SG, Partridge KB (1980) Health education planning: a diagnostic approach. In: Health education planning: a diagnostic approach. Mayfield Publishing Company, Health & Fitness, p 306 Green LW, Kreuter M, Deeds SG, Partridge KB (1980) Health education planning: a diagnostic approach. In: Health education planning: a diagnostic approach. Mayfield Publishing Company, Health & Fitness, p 306
18.
go back to reference Manfredi C, Kaiser K, Matthews AK, Johnson TP (2010) Are racial differences in patient–physician cancer communication and information explained by background, predisposing, and enabling factors? J Health Commun 15(3):272–292CrossRefPubMedPubMedCentral Manfredi C, Kaiser K, Matthews AK, Johnson TP (2010) Are racial differences in patient–physician cancer communication and information explained by background, predisposing, and enabling factors? J Health Commun 15(3):272–292CrossRefPubMedPubMedCentral
19.
go back to reference Hayes DK, Wiltz JL, Fang J, Loustalot F (2023) Less than ideal cardiovascular health among adults is associated with experiencing adverse childhood events: BRFSS 2019. Prev Med 169:107457CrossRefPubMedPubMedCentral Hayes DK, Wiltz JL, Fang J, Loustalot F (2023) Less than ideal cardiovascular health among adults is associated with experiencing adverse childhood events: BRFSS 2019. Prev Med 169:107457CrossRefPubMedPubMedCentral
22.
go back to reference Chapple A, Ziebland S, Herxheimer A, McPherson A, Shepperd S, Miller R (2002) Is ‘watchful waiting’a real choice for men with prostate cancer? A qualitative study. BJU Int 90(3):257–264CrossRefPubMed Chapple A, Ziebland S, Herxheimer A, McPherson A, Shepperd S, Miller R (2002) Is ‘watchful waiting’a real choice for men with prostate cancer? A qualitative study. BJU Int 90(3):257–264CrossRefPubMed
23.
go back to reference Cykert S et al (2010) Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer. JAMA 303(23):2368–2376CrossRefPubMedPubMedCentral Cykert S et al (2010) Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer. JAMA 303(23):2368–2376CrossRefPubMedPubMedCentral
24.
go back to reference Sinding C, Wiernikowski J, Aronson J (2005) Cancer care from the perspectives of older women. Oncol Nurs Forum 32(6) Sinding C, Wiernikowski J, Aronson J (2005) Cancer care from the perspectives of older women. Oncol Nurs Forum 32(6)
25.
go back to reference Ward-Smith P (2003) Brachytherapy for prostate cancer: the patient's perspective. Urol Nurs 23(3):213–217 Ward-Smith P (2003) Brachytherapy for prostate cancer: the patient's perspective. Urol Nurs 23(3):213–217
Metadata
Title
Demographic Disparities and Factors Influencing Cancer Treatment Decision-Making
Authors
Safa Elkefi
Avishek Choudhury
Publication date
03-02-2025
Publisher
Springer US
Published in
Journal of Cancer Education
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-025-02570-w

ASH 2024 Annual Meeting Coverage

inMIND supports tafasitamab addition in follicular lymphoma

Combining tafasitamab with lenalidomide and rituximab significantly improves progression-free survival for patients with relapsed or refractory follicular lymphoma.

Featuring the official presentation video

Read more
SPONSORED

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by:
  • Novartis Pharma AG
Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare
Watch now